This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second Opinion: Discussing the pediatric GHD treatment landscape with current prescribers of Skytrofa to better understand trends of use in clinic
Ticker(s): ASNDWho's the expert?
Institution: Lurie Children's Hospital
- Attending Physician of Endocrinology and Assistant diabetes director at Ann & Robert H. Lurie Children’s Hospital of Chicago; Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine.
- Currently manages 300 patients with pediatric growth hormone deficiency.
- Has prescribed Skytrofa to 30 patients.
Interview GoalThis interview will focus on Skytrofa in pediatric growth hormone deficiency and gain a better understanding of trends of use in the clinic & experience from current prescribers of the medication.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
